This is How A lot You Would Have Made Proudly owning Regeneron Prescribed drugs Inventory In The Final 15 Years – Regeneron Prescribed drugs (NASDAQ:REGN)

Regeneron Prescribed drugs REGN has outperformed the market over the previous 15 years by 12.37% on an annualized foundation producing a median annual return of 24.38%. At the moment, Regeneron Prescribed drugs has a market capitalization of $74.02 billion.

Shopping for $100 In REGN: If an investor had purchased $100 of REGN inventory 15 years in the past, it might be value $2,562.19 as we speak based mostly on a worth of $673.60 for REGN on the time of writing.

Regeneron Prescribed drugs’s Efficiency Over Final 15 Years

Lastly — what is the level of all this? The important thing perception to take from this text is to notice how a lot of a distinction compounded returns could make in your money progress over a time frame.

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.